Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 5, 2009, Pages

  Lacolley, Patrick ^a   Safar, Michel E ^b   Regnault, Veronique ^a   Frohlich, Edward D ^c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Antihypertensive therapy; Pulsatile forces

Indexed keywords

ALPHA5 INTEGRIN; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIURETIC AGENT; FOCAL ADHESION KINASE; OXYGEN RADICAL;

ARTERIAL STIFFNESS; ARTERY WALL; CONTROLLED STUDY; DRUG EFFECT; HEART HEMODYNAMICS; HEART OUTPUT; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MECHANOTRANSDUCTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR RESISTANCE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; ELASTICITY; HUMANS; HYPERTENSION; MECHANOTRANSDUCTION, CELLULAR; PULSATILE FLOW; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE, DIETARY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 70350439914     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00622.2009     Document Type: Review

References (67)

1. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 39: 197-202, 2002. (Pubitemid 34165214)
2. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, Wang JG, Wilkinson IB, Williams B, Vlachopoulos C. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50: 154-160, 2007. (Pubitemid 46986036)
3. Amar J, Ruidavets JB, Peyrieux JC, Mallion JM, Ferrieres J, Safar ME, Chamontin B. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects. Hypertension 46: 151-155, 2005. (Pubitemid 40946506)
4. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol Heart Circ Physiol 259: H324-H332, 1990.
5. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J, Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 18: 1027-1034, 1998. (Pubitemid 28323586)
6. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97: 533-540, 2005. (Pubitemid 41361743)
7. Et-Taouil K, Schiavi P, Levy BI, Plante GE. Sodium intake, large artery stiffness, and proteoglycans in the spontaneously hypertensive rat. Hypertension 38: 1172-1176, 2001. (Pubitemid 34252825)
8. Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens 25: 1915-1920, 2007.
9. Frisbee JC, Lombard JH. Chronic elevations in salt intake and reduced renal mass hypertension compromise mechanisms of arteriolar dilation. Microvasc Res 56: 218-227, 1998. (Pubitemid 28560183)
10. Frohlich ED. The salt conundrum: a hypothesis. Hypertension 50: 161-166, 2007.
11. Frohlich ED, Re R. The Local Cardiac Renin Angiotensin-Aldosterone System. New York: Springer Science & Business Media, 2005.
12. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580: 497-504, 2006. (Pubitemid 43089678)
13. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW Jr. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol Heart Circ Physiol 256: H126-H131, 1989. (Pubitemid 19049895)
14. Henrion D. Pressure and flow-dependent tone in resistance arteries. Role of myogenic tone. Arch Mal Coeur Vaiss 98: 913-921, 2005.
15. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery? J Hypertens 23: 551-556, 2005.
16. Hishikawa K, Luscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 96: 3610-3616, 1997. (Pubitemid 27513440)
17. Ingber D. Integrins as mechanochemical transducers. Curr Opin Cell Biol 3: 841-848, 1991.
18. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol Renal Physiol 276: F218-F227, 1999. (Pubitemid 29102286)
19. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 36: 312-318, 2000.
20. Koffi I, Lacolley P, Kirchengaast M, Pomies JP, Laurent S, Benetos A. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. Eur J Pharmacol 361: 51-60, 1998. (Pubitemid 28522158)
21. Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 38: 439-443, 2001. (Pubitemid 34225680)
22. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 106: 2848-2853, 2002. (Pubitemid 35396986)
23. Lehoux S, Esposito B, Merval R, Loufrani L, Tedgui A. Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species. Arterioscler Thromb Vasc Biol 20: 2366-2372, 2000. (Pubitemid 30825069)
24. Lehoux S, Esposito B, Merval R, Tedgui A. Differential regulation of vascular focal adhesion kinase by steady stretch and pulsatility. Circulation 111: 643-649, 2005. (Pubitemid 40216493)
25. Lehoux S, Tedgui A. Cellular mechanics and gene expression in blood vessels. J Biomech 36: 631-643, 2003. (Pubitemid 36407615)
26. Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol 279: H7-H14, 2000.
27. London GM, Asmar RG, O'Rourke MF, Safar ME; REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 43: 92-99, 2004. (Pubitemid 38045921)
28. 1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol 293: H2597-H2604, 2007.
29. Matrougui K, Schiavi P, Guez D, Henrion D. High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats. Hypertension 32: 176-179, 1998. (Pubitemid 28324145)
30. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677-2685, 2005. (Pubitemid 41532605)
31. Mitchell GF, Vita JA, Larson MG, Parise H, Keyes MJ, Warner E, Vasan RS, Levy D, Benjamin EJ. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 112: 3722-3728, 2005. (Pubitemid 43739512)
32. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52: 372-386, 2001. (Pubitemid 33153100)
33. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94: 978-984, 1994. (Pubitemid 24286437)
34. Navar LG, Prieto-Carrasquero MC, Kobori H. Regulation of renin in JGA and tubules in hypertension. In: The Local Renin-Angiotensin- Aldosterone System. New York: Springer Science & Business Media, 2005, p. 1-224.
35. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles (4th ed.). London: Edward Arnold, 2006, p. 49-94, 193-233, 339-402, 435-502.
36. Okada M, Matsumori A, Ono K, Furukawa Y, Shioi T, Iwasaki A, Matsushima K, Sasayama S. Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 18: 894-901, 1998. (Pubitemid 28272582)
37. Pfeffer MA, Frohlich ED. Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am J Physiol Heart Circ Physiol 291: H2021-H2025, 2006.
38. Phillips SA, Lombard JH. Chronic At1 receptor blockade alters the mechanisms mediating hypoxic dilation in middle cerebral arteries. J Cardiovasc Pharmacol 46: 706-712, 2005.
39. Pries AR, Secomb TW, Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res 32: 654-667, 1996. (Pubitemid 26332305)
40. Re RN. The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues. J Mol Cell Cardiol 21, Suppl 5: 63-69, 1989.
41. Re RN. The intracrine hypothesis and intracellular peptide hormone action. Bioessays 25: 401-409, 2003. (Pubitemid 36433186)
42. Re RN. Tissue renin angiotensin systems. Med Clin North Am 88: 19-38, 2004.
43. Re RN. Toward a theory of intracrine hormone action. Regul Pept 106: 1-6, 2002. (Pubitemid 34607330)
44. Re RN, MacPhee AA, Fallon JT. Specific nuclear binding of angiotensin II by rat liver and spleen nuclei. Clin Sci (Lond) 61, Suppl 7: 245s-247s, 1981.
45. Re RN, Vizard DL, Brown J, Bryan SE. Angiotensin II receptors in chromatin fragments generated by micrococcal nuclease. Biochem Biophys Res Commun 119: 220-227, 1984. (Pubitemid 14166742)
46. Reed R, Kolz C, Potter B, Rocic P. The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth. Arterioscler Thromb Vasc Biol 28: 61-67, 2008.
47. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 108: 2230-2235, 2003. (Pubitemid 37363040)
48. Safar ME, O'Rourke ME. Arterial stiffness in hypertension. In: Handbook of Hypertension. Edinburg: Elsevier, 2006, p. 3-62, 75-136, 459-501.
49. Safar ME, Laurent P. Pulse pressure and arterial stiffness in rats: comparison with humans. Am J Physiol Heart Circ Physiol 285: H1363-H1369, 2003. (Pubitemid 37169487)
50. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107: 2864-2869, 2003. (Pubitemid 36705999)
51. Sartore S, Scatena M, Chiavegato A, Faggin E, Giuriato L, Pauletto P. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J Vasc Res 31: 61-81, 1994. (Pubitemid 24084985)
52. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17: 1192-1200, 2004. (Pubitemid 40029420)
53. Siragy HM. Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations. Curr Opin Nephrol Hypertens 15: 50-53, 2006.
54. Staessen JA, Li Y, Thijs L, Wang JG. Changing concepts on the role of blood pressure reduction in cardiovascular prevention. In: Handbook of Hypertension. Arterial Stiffness in Hypertension. Edinburg: Elsevier, 2006, p. 485-502.
55. Ting CT, Chou CY, Chang MS, Wang SP, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. Effects of adrenergic blockade. Circulation 84: 1049-1057, 1991.
56. Ting CT, Yang TM, Chen JW, Chang MS, Yin FC. Arterial hemodynamics in human hypertension. Effects of angiotensin converting enzyme inhibition. Hypertension 22: 839-846, 1993. (Pubitemid 23358091)
57. Vaccarino V, Holford TR, Krumholz HM. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36: 130-138, 2000. (Pubitemid 30466123)
58. Varagic J, Frohlich ED, Diez J, Susic D, Ahn J, Gonzalez A, Lopez B. Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol 290: H1503-H1509, 2006.
59. Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, Lopez B, Diez J. AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol 294: H853-H858, 2008. (Pubitemid 351253296)
60. Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 45: 586-591, 2005.
61. 1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 280: H2196-H2202, 2001.
62. Westerbacka J, Wilkinson I, Cockcroft J, Utriainen T, Vehkavaara S, Yki-Jarvinen H. Diminished wave reflection in the aorta A novel physiological action of insulin on large blood vessels. Hypertension 33: 1118-1122, 1999. (Pubitemid 29230959)
63. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113: 1213-1225, 2006. (Pubitemid 43754247)
64. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest 96: 2364-2372, 1995.
65. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 106: 2422-2427, 2002. (Pubitemid 35278796)
66. 1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR. Am J Physiol Renal Physiol 289: F871-F879, 2005.
67. Zhu J, Huang T, Lombard JH. Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res 44: 382-390, 2007. (Pubitemid 47312659)